IMRT-treated Prostate Cancer Patients Don’t Have Increased Risk of Secondary Disease, Study Reveals

IMRT-treated Prostate Cancer Patients Don’t Have Increased Risk of Secondary Disease, Study Reveals
Prostate cancer patients treated with intensity-modulated radiation therapy (IMRT) do not have an increased risk of secondary cancers such as leukemia or myelodysplasia, compared to the standard 3D conformal radiotherapy. The study, “Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer,” was published in the online version of JAMA Oncology. IMRT is

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *